Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€87.10
05.05.19
€200.00
04.11.21
113.03%
05.11.21

Could be worthwhile Investment >10% per year
buy
Formycon AG

Start price
Target price
Perf. (%)
€35.10
27.04.19
€53.50
04.11.21
44.73%
05.11.21

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€19.10
15.08.19
€35.00
04.11.21
105.76%
05.11.21

buy
Formycon AG

Start price
Target price
Perf. (%)
€26.30
23.12.18
€78.00
04.11.21
93.16%
05.11.21

buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€1.80
23.12.18
€5.00
04.11.21
-73.72%
05.11.21

buy
Merck KGaA

Start price
Target price
Perf. (%)
€95.46
03.07.19
€129.00
04.11.21
128.05%
05.11.21

buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€5.60
14.04.15
€7.50
04.11.21
-89.13%
05.11.21

buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€67.50
27.07.18
€110.00
04.11.21
174.89%
05.11.21

buy
Merck KGaA

Start price
Target price
Perf. (%)
€82.56
20.06.18
€149.00
04.11.21
163.69%
05.11.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.41
09.11.20
€40.00
09.11.21
18.27%
02.11.21

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Nanorepro AG

Start price
Target price
Perf. (%)
€8.95
16.02.21
€5.00
16.02.22
-7.49%
18.10.21

Below average Management
Little innovation
Few uniques
Dependend from some customers or products
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
18.10.20
€50.00
04.11.21
6.54%
12.10.21

Could be worthwhile Investment >10% per year
Evotec SE

Start price
Target price
Perf. (%)
€42.98
23.08.21
-
23.08.22
-7.56%
11.10.21

Risky Investment
buy
Formycon AG

Start price
Target price
Perf. (%)
€60.40
18.01.21
€80.00
18.01.22
-9.93%
04.10.21

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.40
26.09.21
-
26.09.22
-6.82%
03.10.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€5.64
27.01.21
€8.00
27.01.22
9.75%
28.09.21

Could be worthwhile Investment >10% per year
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€413.70
18.06.21
€600.00
18.06.22
35.75%
27.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€8.60
15.02.21
€20.00
15.02.22
5.47%
23.09.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€53.12
15.03.21
-
15.03.22
-15.68%
20.09.21

buy
Merck KGaA

Start price
Target price
Perf. (%)
€144.55
11.01.21
€145.00
11.01.22
42.10%
12.09.21

Could be very worthwhile Investment >20% year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.22
04.01.21
€75.00
04.01.22
11.33%
05.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€47.81
30.08.21
€53.00
30.08.22
5.67%
04.09.21

Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Higher risks for its business
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€16.00
12.03.21
€22.00
12.03.22
-62.19%
12.08.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€2.30
17.06.20
€5.00
04.11.21
73.91%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
High valuation
buy
Stratec SE

Start price
Target price
Perf. (%)
€121.80
20.07.21
€135.00
20.07.22
4.76%
30.07.21

Risky Investment